196091-24-4

Basic information

• Product Name: 1,3-Benzodioxol-5-amine, 4-methyl-
• Synonyms: 1,3-Benzodioxol-5-amine, 4-methyl-
• CAS NO: 196091-24-4
• Molecular Formula: C8H9NO2
• Molecular Weight: 151.16
• Mol File: 196091-24-4.mol

Chemical Properties

• Boiling Point: 280.3±39.0 °C(Predicted)
• Appearance: /
• Density: 1.268±0.06 g/cm3(Predicted)
• PKA: 4.63±0.20(Predicted)
• CAS DataBase Reference: 1,3-Benzodioxol-5-amine, 4-methyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Benzodioxol-5-amine, 4-methyl-(196091-24-4)
• EPA Substance Registry System: 1,3-Benzodioxol-5-amine, 4-methyl-(196091-24-4)

Safety Data

• Hazardous Substances Data: 196091-24-4(Hazardous Substances Data)

Usage

Derivative of

1,3-Benzodioxole (safrole)

Found in

Essential oils of various plants

Usage

Synthesis of pharmaceuticals and organic compounds

Reactivity

Versatile

Functional groups

Amine and methyl groups

Psychoactive properties

Potentially psychoactive

Studies

Pharmacology and medicinal chemistry

Regulatory restrictions

May have restrictions in some regions due to association with illicit drug manufacturing

Upstream product

• 20487-10-9 4-methyl-benzo[1,3]dioxole 
• 72744-52-6 2-nitro-5,6-(methylenedioxy)toluene 
• 72744-53-7 3-nitro-5,6-(methylenedioxy)toluene 

Relevant articles and documents

2-IMIDAZOLINYLAMINO HETEROCYCLIC COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS

The subject invention relates to compounds having the structure: STR1 wherein (a) n is an integer from 1 to about 3; (b) X and Y are each independently selected from O, S and CH 2, with at least one of X and Y being O or S;(c) R is unsubstituted, straight or branched chain alkanyl or alkanoxy having from 1 to about 3 non-hydrogen atoms; and(d) R' is selected from hydrogen, methyl, cyano, and halo; pharmaceutical compositions containing such compounds; and the use of such compounds for preventing or treating of disorders modulated by alpha-2 adrenoceptors.

2-IMIDAZOLINYLAMINO HETEROCYCLIC COMPOUNDS USEFUL AS ALPHA-2 ADRENOCEPTOR AGONISTS

The subject invention relates to compounds having the structure: STR1 wherein (a) n is an integer from 1 to about 3; (b) X and Y are each independently selected from O, S and CH 2, with at least one of X and Y being O or S;(c) R is unsubstituted, straight or branched chain alkanyl or alkanoxy having from 1 to about 3 non-hydrogen atoms; and(d) R' is selected from hydrogen, methyl, cyano, and halo; pharmaceutical compositions containing such compounds; and the use of such compounds for preventing or treating one or more of respiratory disorders, ocular disorders, and gastrointestinal disorders.